期刊
NANO TODAY
卷 4, 期 5, 页码 399-413出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.nantod.2009.07.001
关键词
Molecular imaging; Nanoparticle; Internal radiotherapy; Cancer; Positron emission tomography (PET); Single-photon emission computed tomography (SPECT)
资金
- NCRR NIH HHS [UL1 RR025011-01, UL1 RR025011] Funding Source: Medline
This review summarizes the current state-of-the-art of radiolabeled nanoparticles for molecular imaging and internal radiotherapy applications targeting cancer. With the capacity to provide enormous flexibility, radiolabeled nanoparticles have the potential to profoundly impact disease diagnosis and patient management in the near future. Currently, the major challenges facing the research on radiolabeled nanoparticles are desirable (tumor) targeting efficacy, robust chemistry for both radionuclide encapsulation/incorporation and targeting ligand conjugation, favorable safety profile, as well as certain commercial and regulatory hurdles. (C) 2009 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据